Hepatitis C virus infection induces elevation of CXCL10 in human brain microvascular endothelial cells

Journal of Medical Virology

Volumn 88, Issue 9, 2016, Pages 1596-1603

  Liu, Yuan ^a   Chen, Li ^a   Zou, Ziying ^a   Zhu, Bing ^a   Hu, Zonghai ^a   Zeng, Ping ^a   Wu, Lijuan ^a   Xiong, Jie ^a  

^a CHENGDU MILITARY GENERAL HOSPITAL   (China)

Author keywords

CXCL10; HBMECs; HCV; neuroinflammation; NF B

Indexed keywords

CHEMOKINE RECEPTOR CX3CR1; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA;

ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; ENCEPHALITIS; ENDOTHELIUM CELL; HEPATITIS C; HUMAN; HUMAN CELL; MICROVASCULATURE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; UPREGULATION; VIRUS CELL INTERACTION;

EID: 84977648821     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24504     Document Type: Article

References (24)

1. Brownell J, Bruckner J, Wagoner J, Thomas E, Loo YM, Gale M, Jr., Liang TJ, Polyak SJ. 2014. Direct, interferon-independent activation of the CXCL10 promoter by NF-κB and interferon regulatory factor 3 during hepatitis C virus infection. J Virol 88:1582–1590.
2. Brownell J, Wagoner J, Lovelace ES, Thirstrup D, Mohar I, Smith W, Giugliano S, Li K, Crispe IN, Rosen HR, Polyak SJ. 2013. Independent, parallel pathways to CXCL10 induction in HCV-infected hepatocytes. J Hepatol 59:701–708.
3. Carta MG, Angst J, Moro MF, Mura G, Hardoy MC, Balestrieri C, Chessa L, Serra G, Lai ME, Farci P. 2012. Association of chronic hepatitis C with recurrent brief depression. J Affect Disord 141:361–366.
4. Fahey S, Dempsey E, Long A. 2014. The role of chemokines in acute and chronic hepatitis C infection. Cell Mol Immunol 11:25–40.
5. Fletcher NF, Wilson GK, Murray J, Hu K, Lewis A, Reynolds GM, Stamataki Z, Meredith LW, Rowe IA, Luo G, Lopez-Ramirez MA, Baumert TF, Weksler B, Couraud PO, Kim KS, Romero IA, Jopling C, Morgello S, Balfe P, McKeating JA. 2012. Hepatitis C virus infects the endothelial cells of the blood-brain barrier. Gastroenterology 142:634–643.
6. Forton DM, Allsop JM, Cox IJ, Hamilton G, Wesnes K, Thomas HC, Taylor-Robinson SD. 2005. A review of cognitive impairment and cerebral metabolite abnormalities in patients with hepatitis C infection. AIDS 19:S53–S63.
7. García-Álvarez M, Berenguer J, Guzmán-Fulgencio M, Micheloud D, Catalán P, Muñoz-Fernandez MA, Alvarez E, Resino S. 2011. High plasma fractalkine (CX3CL1) levels are associated with severe liver disease in HIV/HCV co-infected patients with HCV genotype 1. Cytokine 5:244–248.
8. Goh J, Coughlan B, Quinn J, O'Keane JC, Crowe J. 1999. Fatigue does not correlate with the degree of hepatitis or the presence of autoimmune disorders in chronic hepatitis C infection. Eur J Gastroenterol Hepatol 11:833–838.
9. Helbig KJ, Ruszkiewicz A, Lanford RE, Berzsenyi MD, Harley HA, McColl SR, Beard MR. 2009. Differential expression of the CXCR3 ligands in chronic hepatitis C virus (HCV) infection and their modulation by HCV in vitro. J Virol 83:836–846.
10. Kastenbauer S, Koedel U, Wick M, Kieseier BC, Hartung HP, Pfister HW. 2003. CSF and serum levels of soluble fractalkine (CX3CL1) in inflammatory diseases of the nervous system. Neuroimmunol 137:210–217.
11. Liu Y, Zou Z, Zhu B, Hu Z, Zeng P. 2013. CXCL10 decreases GP73 expression in hepatoma cells at the early stage of hepatitis C virus (HCV) infection. Int J Mol Sci 14:24230–24241.
12. Mills JH, Alabanza LM, Mahamed DA, Bynoe MS. 2012. Extracellular adenosine signaling induces CX3CL1 expression in the brain to promote experimental autoimmune encephalomyelitis. J Neuroinflammation 9:193.
13. Neuman MG, Benhamou JP, Marcellin P, Valla D, Malkiewicz IM, Katz GG, Trepo C, Bourliere M, Cameron RG, Cohen L, Morgan M, Schmilovitz-Weiss H, Ben-Ari Z. 2007. Cytokine-chemokine and apoptotic signatures in patients with hepatitis C. Transl Res 149:126–136.
14. Parvaiz F, Manzoor S, Tariq H, Javed F, Fatima K, Qadri I. 2011. Hepatitis C virus infection: Molecular pathways to insulin resistance. Virol J 8:474.
15. Poynard T, Yuen MF, Ratziu V, Lai CL. 2003. Viral hepatitis C. Lancet 362:2095–2100.
16. Roe B, Coughlan S, Hassan J, Grogan A, Farrell G, Norris S, Bergin C, Hall WW. 2007. Elevated serum levels of interferon- gamma -inducible protein-10 in patients coinfected with hepatitis C virus and HIV. J Infect Dis 196:1053–1057.
17. Schroder K, Hertzog PJ, Ravasi T, Hume DA. 2004. Interferon-gamma: An overview of signals, mechanisms and functions. J Leukoc Biol 75:163–189.
18. Semple BD, Kossmann T, Morganti-Kossmann MC. 2010. Role of chemokines in CNS health and pathology: A focus on the CCL2/CCR2 and CXCL8/CXCR2 networks. J Cereb Blood Flow Meta 30:459–473.
19. Shepard CW, Finelli L, Alter MJ. 2005. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5:558–567.
20. Simpson JE, Newcombe J, Cuzner ML, Woodroofe MN. 2000. Expression of the interferon-gamma-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions. Neuropathol Appl Neurobiol 26:133–142.
21. Spurrell JC, Wiehler S, Zaheer RS, Sanders SP, Proud D. 2005. Human airway epithelial cells produce IP-10 (CXCL10) in vitro and in vivo upon rhinovirus infection. Am J Physiol Lung Cell Mol Physiol 289:L85–L95.
22. Weissenborn K, Tryc AB, Heeren M, Worthmann H, Pflugrad H, Berding G, Bokemeyer M, Tillmann HL, Goldbecker A. 2009. Hepatitis C virus infection and the brain. Metab Brain Dis 24:197–210.
23. Zampino R, Marrone A, Restivo L, Guerrera B, Sellitto A, Rinaldi L, Romano C, Adinolfi LE. 2013. Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations. World J Hepatol 5:528–540.
24. Zignego AL, Giannini C, Gragnani L. 2012. HCV and lymphoproliferation. Clin Dev Immunol 2012:980942.